loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 202588 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SANDOZ (1)

filter

01 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL (1)

filter

01 RX (1)

filter

01 LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) (1)

filter

01 No (1)

URL Supplier Web Content
CAPSULE, TABLET, C...
500MG;500MG;30MG
2014-03-04
202588
LANSOPRAZOLE, AMOX...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202588

Looking for FDA Orange Book APPLICATION 202588 1

19

Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for A global leader in antibiotics.

One of their notable products is AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE, with a corresponding application number 202588.

Regulatory Information RX

With a dosage strength 500MG;500MG;30MG

Dosage Form Route CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS; ORAL

Reference Listed Drug No

Approved since 2014-03-04

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY